A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache
Status:
Recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled
study to evaluate the efficacy and safety of erenumab against placebo in subjects with
chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are
diagnosed with medication overuse headache (MOH).